COPANLISIB for Marginal zone lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 29 adverse event reports in the FDA FAERS database where COPANLISIB was used for Marginal zone lymphoma.
Most Reported Side Effects for COPANLISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 58 | 16.3% | 10 | 53 |
| Off label use | 43 | 12.1% | 1 | 20 |
| Hyperglycaemia | 27 | 7.6% | 2 | 18 |
| Hypertension | 24 | 6.8% | 1 | 12 |
| Rash maculo-papular | 24 | 6.8% | 4 | 16 |
| Pneumonia | 20 | 5.6% | 6 | 15 |
| Sepsis | 19 | 5.4% | 8 | 12 |
| Diarrhoea | 18 | 5.1% | 2 | 5 |
| Rash | 16 | 4.5% | 3 | 10 |
| Febrile neutropenia | 15 | 4.2% | 6 | 8 |
| Neutropenia | 15 | 4.2% | 3 | 5 |
| Neutropenic sepsis | 15 | 4.2% | 2 | 14 |
| Anaemia | 14 | 3.9% | 4 | 12 |
| Dyspnoea | 14 | 3.9% | 6 | 12 |
| Cytopenia | 13 | 3.7% | 0 | 11 |
Other Indications for COPANLISIB
Follicular lymphoma (42)
B-cell lymphoma (38)
Product used for unknown indication (23)
Non-hodgkin's lymphoma recurrent (20)
Diffuse large b-cell lymphoma (17)
Non-hodgkin's lymphoma (11)
B-cell lymphoma recurrent (10)
Diffuse large b-cell lymphoma recurrent (10)
Non-hodgkin's lymphoma unspecified histology indolent (6)
Colorectal cancer (5)
Other Drugs Used for Marginal zone lymphoma
RITUXIMAB (706)
IBRUTINIB (519)
LENALIDOMIDE (321)
OBINUTUZUMAB (188)
ETOPOSIDE (176)
BENDAMUSTINE (174)
CYCLOPHOSPHAMIDE (173)
IFOSFAMIDE (151)
METHOTREXATE (138)
DOXYCYCLINE (135)